Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.96 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | CCR1 | P32246 | 5/20 | 0.60 |
| ▸ | CCR8 | P51685 | 5/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.60 |
| ▸ | CCR5 | P51681 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.60 |
| ▸ | MMP2 | P08253 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | GMNN | O75496 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | MMP9 | P14780 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | MMP8 | P22894 | 1/20 | 0.60 |
| ▸ | THPO | P40225 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8313 | 0.98 | LMNA (1.00) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL6513577 | 0.98 | LMNA (1.00) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL3862777 | 0.96 | LMNA (0.96) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL10789328 | 0.96 | LMNA (0.96) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL8728454 | 0.96 | LMNA (0.96) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL1681333 | 0.96 | LMNA (0.96) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL1003398 | 0.96 | LMNA (0.96) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL722331 | 0.96 | LMNA (0.96) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL4447950 | 0.96 | LMNA (0.96) | LMNACYP3A4CCR1CCR8MAPT | |
| SCHEMBL4858817 | 0.96 | LMNA (0.96) | LMNACYP3A4CCR1CCR8MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504372-A | Method for synthesizing 4-tert-butoxy styrene | 西安近代化学研究所 | 2025-02-25 | — | — | CN | claimed |
| CN-117624249-A | Red light-emitting iridium complex viscosity probe, preparation method and application thereof | 安徽工业大学 | 2024-03-01 | — | — | CN | claimed |
| CN-119504372-A | Method for synthesizing 4-tert-butoxy styrene | 西安近代化学研究所 | 2025-02-25 | — | — | CN | disclosed |
| CN-119504372-A | Method for synthesizing 4-tert-butoxy styrene | 西安近代化学研究所 | 2025-02-25 | — | — | CN | disclosed |
| CN-118103479-A | Organic solid up-conversion material | 出光兴产株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-117624249-A | Red light-emitting iridium complex viscosity probe, preparation method and application thereof | 安徽工业大学 | 2024-03-01 | — | — | CN | disclosed |
| CN-117181265-A | Preparation method of efficient catalyst for preparing DMF (dimethyl formamide) by carbon dioxide hydrogenation | 中国石油大学(华东) | 2023-12-08 | — | — | CN | disclosed |
| WO-2023063289-A1 | ORGANIC SOLID UP-CONVERSION MATERIAL | 出光興産株式会社 | 2023-04-20 | — | — | WO | disclosed |
| US-20160312113-A1 | Optical Wavelength Conversion Element Containing Ionic Liquid, And Article Equipped With Said Optical Wavelength Conversion Element | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2016-10-27 | — | — | US | disclosed |
| CN-105874033-A | Optical wavelength conversion element containing ionic liquid and article comprising same | 日本化药株式会社 | 2016-08-17 | — | — | CN | disclosed |
| CN-102484923-B | Light-emitting component, light-emitting device and manufacture method thereof | SEMICONDUCTOR ENERGY LABORATORY CO.,LTD. (JP) | 2016-05-04 | — | — | CN | disclosed |
| CN-103228612-B | With the method that primary alconol homogeneous catalysis high selectivity direct aminatin is primary amine by high liquid/vapor volume ratio and/or high pressure ammonia | EVONIK DEGUSSA GMBH (DE) | 2016-03-23 | — | — | CN | disclosed |
| US-8927773-B2 | Process for the direct amination of secondary alcohols with ammonia to give primary amines | EVONIK DEGUSSA GMBH (DE) | 2015-01-06 | — | — | US | disclosed |
| US-8835691-B2 | Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures | EVONIK DEGUSSA GMBH (DE) | 2014-09-16 | — | — | US | disclosed |
| US-20130245276-A1 | PROCESS FOR HOMOGENEOUSLY CATALYZED, HIGHLY SELECTIVE DIRECT AMINATION OF PRIMARY ALCOHOLS WITH AMMONIA TO PRIMARY AMINES WITH A HIGH VOLUME RATIO OF LIQUID PHASE TO GAS PHASE AND/OR HIGH PRESSURES | EVONIK DEGUSSA GMBH (DE) | 2013-09-19 | — | — | US | disclosed |
| CN-103228612-A | Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures | EVONIK DEGUSSA GMBH | 2013-07-31 | — | — | CN | disclosed |
| US-20130165672-A1 | PROCESS FOR THE DIRECT AMINATION OF SECONDARY ALCOHOLS WITH AMMONIA TO GIVE PRIMARY AMINES | EVONIK DEGUSSA GMBH (DE) | 2013-06-27 | — | — | US | disclosed |
| CN-103097324-A | Process for the direct amination of secondary alcohols with ammonia to give primary amines | EVONIK DEGUSSA GMBH | 2013-05-08 | — | — | CN | disclosed |
| CN-102484923-A | Light-emitting element, light-emitting device, and method for manufacturing the same | SEMICONDUCTOR ENERGY LAB | 2012-05-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165672-A1 | PROCESS FOR THE DIRECT AMINATION OF SECONDARY ALCOHOLS WITH AMMONIA TO GIVE PRIMARY AMINES | ADH1C, ADH5, ADH1A | LMNA 1154/4885CYP3A4 400/4885CCR1 2988/4885 |
| US-20130245276-A1 | PROCESS FOR HOMOGENEOUSLY CATALYZED, HIGHLY SELECTIVE DIRECT AMINATION OF PRIMARY ALCOHOLS WITH AMMONIA TO PRIMARY AMINES WITH A HIGH VOLUME RATIO OF LIQUID PHASE TO GAS PHASE AND/OR HIGH PRESSURES | ADH1C, ADH1A, ADH5 | LMNA 1050/4885CYP3A4 570/4885CCR1 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.